After two months as FDA acting commissioner, Ned Sharpless said he would like to be nominated for the position permanently, though he acknowledged the decision ultimately lies with the White House. The former National Cancer Institute (NCI) director said he believes having a permanent commissioner in place would provide a strong voice for the agency, and he said he would like to help FDA develop its workforce, modernize clinical trials and facilitate the development of non-cancer therapies. “FDA needs a...